Clinical trial
Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16…
NCT00365378 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00365378 |
|---|---|
| Title | Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005) |
| Official title | Study of Pilot Manufacturing Lot of HPV 16 Virus-Like Particle (VLP) Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HPV 16 Infection |
| Intervention type | Biological |
| Interventions | Comparator: HPV 16 L1 Vaccine, Comparator: Placebo |
| Enrollment | 2,409 |
| Start date | Sep 1, 1999 |
| Primary completion | Mar 1, 2004 |
| Completion | Jul 1, 2009 |
| First posted | Aug 17, 2006 |
| Last update posted | Oct 23, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: